首页 > 最新文献

Neurointervention最新文献

英文 中文
Use of Distal Intracranial Catheters for Better Working View of Cerebral Aneurysms Hidden by Parent Artery or Its Branches: A Technical Note. 使用远端颅内导管对隐藏于主动脉或其分支的脑动脉瘤有更好的工作视野:技术说明。
Q4 CLINICAL NEUROLOGY Pub Date : 2021-11-01 Epub Date: 2021-10-07 DOI: 10.5469/neuroint.2021.00269
Ehab Mahmoud, Samuel Lenell, Christoffer Nyberg, Ljubisa Borota

A good working view is critical for safe and successful endovascular treatment of cerebral aneurysms. In a few cases, endovascular treatment of cerebral aneurysms may be challenging due to difficulty in obtaining a proper working view. In this report of 6 cases, we described the advantage of using a distal intracranial catheter (DIC) to achieve better visualization of cerebral aneurysms hidden by a parent artery or its branches. Between September 2017 and January 2021, we treated 390 aneurysms with endovascular techniques. In 6 cases in which it was difficult to obtain a proper working view, the DIC was placed distally close to the aneurysm in order to remove the parent artery projection from the working view and obtain better visualization of the aneurysm. Clinical and procedural outcomes and complications were evaluated. The position of the DIC was above the internal carotid artery siphon in the 6 cases. All aneurysms were successfully embolized. Raymond-Roy class 1 occlusion was achieved in all 4 unruptured aneurysms, while the result was class 2 in the 2 ruptured aneurysms. Placement of the DIC was atraumatic without dissections or significant catheter-induced vasospasm in all patients. Transient dysphasia was seen in 2 cases and transient aphasia in 1. Using this technique, we have found it possible to better visualize the aneurysm sac or neck and thereby treat cases we otherwise would have considered untreatable.

良好的工作视野对安全、成功地进行脑动脉瘤腔内治疗至关重要。在少数情况下,由于难以获得适当的工作视图,脑动脉瘤的血管内治疗可能具有挑战性。在这6例病例的报告中,我们描述了使用远端颅内导管(DIC)的优势,以更好地显示隐藏在父动脉或其分支中的脑动脉瘤。2017年9月至2021年1月,我们使用血管内技术治疗了390例动脉瘤。在6例难以获得正确工作视图的病例中,DIC被放置在靠近动脉瘤的远端,以便从工作视图中去除载动脉投影,获得更好的动脉瘤可视化。评估临床和手术结果及并发症。6例DIC位于颈内动脉虹吸上方。所有动脉瘤均成功栓塞。4个未破裂动脉瘤均达到Raymond-Roy 1级闭塞,2个破裂动脉瘤为2级闭塞。在所有患者中,DIC的放置是无伤性的,没有出现剥离或明显的导管引起的血管痉挛。短暂性言语障碍2例,短暂性失语1例。使用这项技术,我们发现可以更好地观察动脉瘤囊或颈部,从而治疗我们认为无法治疗的病例。
{"title":"Use of Distal Intracranial Catheters for Better Working View of Cerebral Aneurysms Hidden by Parent Artery or Its Branches: A Technical Note.","authors":"Ehab Mahmoud,&nbsp;Samuel Lenell,&nbsp;Christoffer Nyberg,&nbsp;Ljubisa Borota","doi":"10.5469/neuroint.2021.00269","DOIUrl":"https://doi.org/10.5469/neuroint.2021.00269","url":null,"abstract":"<p><p>A good working view is critical for safe and successful endovascular treatment of cerebral aneurysms. In a few cases, endovascular treatment of cerebral aneurysms may be challenging due to difficulty in obtaining a proper working view. In this report of 6 cases, we described the advantage of using a distal intracranial catheter (DIC) to achieve better visualization of cerebral aneurysms hidden by a parent artery or its branches. Between September 2017 and January 2021, we treated 390 aneurysms with endovascular techniques. In 6 cases in which it was difficult to obtain a proper working view, the DIC was placed distally close to the aneurysm in order to remove the parent artery projection from the working view and obtain better visualization of the aneurysm. Clinical and procedural outcomes and complications were evaluated. The position of the DIC was above the internal carotid artery siphon in the 6 cases. All aneurysms were successfully embolized. Raymond-Roy class 1 occlusion was achieved in all 4 unruptured aneurysms, while the result was class 2 in the 2 ruptured aneurysms. Placement of the DIC was atraumatic without dissections or significant catheter-induced vasospasm in all patients. Transient dysphasia was seen in 2 cases and transient aphasia in 1. Using this technique, we have found it possible to better visualize the aneurysm sac or neck and thereby treat cases we otherwise would have considered untreatable.</p>","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":"16 3","pages":"267-274"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e0/2b/neuroint-2021-00269.PMC8561035.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39490086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cascade of Complications Following Carotid Body Tumor Excision. 颈动脉体肿瘤切除后并发症的级联反应。
Q4 CLINICAL NEUROLOGY Pub Date : 2021-11-01 Epub Date: 2021-09-29 DOI: 10.5469/neuroint.2021.00248
Pawan K Garg, Sarbesh Tiwari, Tushar S Ghosh, Surendra Patel, Ankur Sharma, Pushpinder S Khera

Carotid body tumor excision can lead to various complications including vascular injury and pseudoaneurysm formation. Here we describe a case of carotid body tumor excision followed by series of complications including pseudoaneurysm formation, failure of primary surgical repair, carotid stump syndrome following parent artery occlusion, and persistent hypotension.

颈动脉体肿瘤切除可导致多种并发症,包括血管损伤和假性动脉瘤的形成。在此,我们报告一例颈动脉体肿瘤切除后出现的一系列并发症,包括假性动脉瘤形成、初级手术修复失败、颈动脉残端综合征后的母动脉闭塞和持续低血压。
{"title":"Cascade of Complications Following Carotid Body Tumor Excision.","authors":"Pawan K Garg,&nbsp;Sarbesh Tiwari,&nbsp;Tushar S Ghosh,&nbsp;Surendra Patel,&nbsp;Ankur Sharma,&nbsp;Pushpinder S Khera","doi":"10.5469/neuroint.2021.00248","DOIUrl":"https://doi.org/10.5469/neuroint.2021.00248","url":null,"abstract":"<p><p>Carotid body tumor excision can lead to various complications including vascular injury and pseudoaneurysm formation. Here we describe a case of carotid body tumor excision followed by series of complications including pseudoaneurysm formation, failure of primary surgical repair, carotid stump syndrome following parent artery occlusion, and persistent hypotension.</p>","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":"16 3","pages":"298-302"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e2/26/neuroint-2021-00248.PMC8561026.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39466116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Adjustment of Malpositioned Woven EndoBridge Device Using Gooseneck Snare: Complication Management Technique. 鹅颈圈套调整错位编织桥内装置:并发症处理技术。
Q4 CLINICAL NEUROLOGY Pub Date : 2021-11-01 Epub Date: 2021-10-12 DOI: 10.5469/neuroint.2021.00318
Krishna Amuluru, Fawaz Al-Mufti, Daniel H Sahlein, John Scott, Andrew Denardo

The Woven EndoBridge (WEB) is an intrasaccular flow-disrupting device for the treatment of wide-necked saccular cerebral aneurysms. As with any neuroendovascular device, complications in the form of malpositioning and migration must be managed quickly and safely. Few studies have reported complication management techniques in instances of dislocated or migrated WEB devices. We retrospectively describe a case of a malpositioned WEB device that was successfully adjusted with the use of a gooseneck snare. Multiple other intra-procedural bailout strategies for management of WEB malposition and migration were considered, and are herein discussed. Operators should be aware of the causes of WEB malposition and a variety of bailout strategies.

Woven EndoBridge (WEB)是一种囊内血流阻断装置,用于治疗宽颈囊状脑动脉瘤。与任何神经血管内装置一样,以错位和移位形式出现的并发症必须快速安全地处理。很少有研究报道在脱位或移位的情况下的并发症管理技术。我们回顾性地描述了一个错误定位的WEB装置,成功地调整使用鹅颈圈套的情况。许多其他的程序内救助策略的管理不当和迁移被考虑,并在此讨论。经营者应了解定位错误的原因和各种救助策略。
{"title":"Adjustment of Malpositioned Woven EndoBridge Device Using Gooseneck Snare: Complication Management Technique.","authors":"Krishna Amuluru,&nbsp;Fawaz Al-Mufti,&nbsp;Daniel H Sahlein,&nbsp;John Scott,&nbsp;Andrew Denardo","doi":"10.5469/neuroint.2021.00318","DOIUrl":"https://doi.org/10.5469/neuroint.2021.00318","url":null,"abstract":"<p><p>The Woven EndoBridge (WEB) is an intrasaccular flow-disrupting device for the treatment of wide-necked saccular cerebral aneurysms. As with any neuroendovascular device, complications in the form of malpositioning and migration must be managed quickly and safely. Few studies have reported complication management techniques in instances of dislocated or migrated WEB devices. We retrospectively describe a case of a malpositioned WEB device that was successfully adjusted with the use of a gooseneck snare. Multiple other intra-procedural bailout strategies for management of WEB malposition and migration were considered, and are herein discussed. Operators should be aware of the causes of WEB malposition and a variety of bailout strategies.</p>","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":"16 3","pages":"275-279"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/76/1a/neuroint-2021-00318.PMC8561038.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39505981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Fund Correction: Unrecognized Ruptured Intracranial Aneurysm Presenting as Cerebral Vasospasm-Induced Ischemic Stroke: A Case Report. 基金更正:未被识别的破裂颅内动脉瘤表现为脑血管痉挛引起的缺血性中风:1例报告。
Q4 CLINICAL NEUROLOGY Pub Date : 2021-11-01 Epub Date: 2021-10-21 DOI: 10.5469/neuroint.2021.00017.e1
Joong-Goo Kim, Chul-Hoo Kang, Jay Chol Choi, Jong-Kook Rhim
{"title":"Fund Correction: Unrecognized Ruptured Intracranial Aneurysm Presenting as Cerebral Vasospasm-Induced Ischemic Stroke: A Case Report.","authors":"Joong-Goo Kim,&nbsp;Chul-Hoo Kang,&nbsp;Jay Chol Choi,&nbsp;Jong-Kook Rhim","doi":"10.5469/neuroint.2021.00017.e1","DOIUrl":"https://doi.org/10.5469/neuroint.2021.00017.e1","url":null,"abstract":"","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":"16 3","pages":"304"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c1/24/neuroint-2021-00017-e1.PMC8561029.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39540725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ten Years of Clinical Evaluation of the Woven EndoBridge: A Safe and Effective Treatment for Wide-Neck Bifurcation Aneurysms. 编织内桥十年临床评价:一种安全有效的治疗宽颈分叉动脉瘤的方法。
Q4 CLINICAL NEUROLOGY Pub Date : 2021-11-01 Epub Date: 2021-10-22 DOI: 10.5469/neuroint.2021.00395
Laurent Pierot

Intrasaccular flow disruption is an innovative approach for the endovascular treatment of intracranial aneurysms. As of now, only one device is currently available worldwide: the Woven EndoBridge (WEB) device (MicroVention, Aliso Viejo, CA, USA). After 10 years of clinical use and careful clinical evaluation of the WEB device by multiple prospective, multicenter studies, this article is summarizing the current knowledge regarding this endovascular technique; indications, modalities, safety and efficacy of the WEB procedure are described.

囊内血流阻断是血管内治疗颅内动脉瘤的一种创新方法。到目前为止,全球只有一种设备可用:Woven EndoBridge (WEB)设备(MicroVention, Aliso Viejo, CA, USA)。经过10年的临床使用和多前瞻性、多中心研究对该装置的仔细临床评估,本文总结了目前关于这种血管内技术的知识;描述了该手术的适应症、方式、安全性和有效性。
{"title":"Ten Years of Clinical Evaluation of the Woven EndoBridge: A Safe and Effective Treatment for Wide-Neck Bifurcation Aneurysms.","authors":"Laurent Pierot","doi":"10.5469/neuroint.2021.00395","DOIUrl":"https://doi.org/10.5469/neuroint.2021.00395","url":null,"abstract":"<p><p>Intrasaccular flow disruption is an innovative approach for the endovascular treatment of intracranial aneurysms. As of now, only one device is currently available worldwide: the Woven EndoBridge (WEB) device (MicroVention, Aliso Viejo, CA, USA). After 10 years of clinical use and careful clinical evaluation of the WEB device by multiple prospective, multicenter studies, this article is summarizing the current knowledge regarding this endovascular technique; indications, modalities, safety and efficacy of the WEB procedure are described.</p>","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":"16 3","pages":"211-221"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7b/93/neuroint-2021-00395.PMC8561039.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39540729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Silk® Flow Diverter Device for Intracranial Aneurysm Treatment: A Systematic Review and Meta-Analysis. Silk®颅内动脉瘤分流器治疗:系统综述和荟萃分析
Q4 CLINICAL NEUROLOGY Pub Date : 2021-11-01 Epub Date: 2021-09-14 DOI: 10.5469/neuroint.2021.00234
William A Florez, Ezequiel Garcia-Ballestas, Gabriel Alexander Quiñones-Ossa, Tariq Janjua, Subhas Konar, Amit Agrawal, Luis Rafael Moscote-Salazar

Flow diverters have become a critical instrument for complex aneurysms treatment. However, limited data are currently available regarding short and long-term outcomes for the Silk flow diverter. The objective of the study is to determine neurological prognosis and mortality rates for the Silk flow diversion device used in intracranial aneurysms. A systematic review with meta-analysis was performed using databases. The following descriptors were used for the search: "SILK", "Flow Diverter", "Mortality", and "Prognosis". The following data were extracted: mortality, good functional outcome, Glasgow outcome scale, complete or near-complete occlusion rates, rate of retreatment, and complications (thromboembolic and hemorrhagic complications). A total of 14 studies were selected. Among the 14 studies, 13 were retrospective observational cohort studies and 1 was a prospective observational cohort study. The mortality rate was 2.84%. The clinical good outcomes rate was 93.3%. The poor outcome rate was 6.6%. The overall thromboembolic complication rate was 6.06% (95% confidence interval [CI] 0.00-6.37, P=0.12, I2=3.13%). The total hemorrhagic complication rate was 1.62% (95% CI 0.00-5.34, P=0.28, I2=1.56%). The complete aneurysm occlusion rate was 80.4% (95% CI 8.65-9.38, P<0.0001, I2=9.09%). The Silk diverter device has a good safety and efficacy profile for treating intracranial aneurysms with high complete occlusion rates.

分流器已成为复杂动脉瘤治疗的重要工具。然而,目前关于Silk分流器的短期和长期效果的数据有限。该研究的目的是确定用于颅内动脉瘤的丝流转移装置的神经预后和死亡率。使用数据库进行系统评价和荟萃分析。以下描述符用于搜索:“SILK”,“Flow Diverter”,“Mortality”和“Prognosis”。提取以下数据:死亡率、良好的功能结局、格拉斯哥结局量表、完全或接近完全闭塞率、再治疗率和并发症(血栓栓塞和出血性并发症)。共选择了14项研究。14项研究中,13项为回顾性观察队列研究,1项为前瞻性观察队列研究。死亡率为2.84%。临床优良率为93.3%。不良转归率为6.6%。总体血栓栓塞并发症发生率为6.06%(95%可信区间[CI] 0.00-6.37, P=0.12, I2=3.13%)。总出血并发症发生率为1.62% (95% CI 0.00 ~ 5.34, P=0.28, I2=1.56%)。动脉瘤完全闭塞率为80.4% (95% CI 8.65 ~ 9.38, P
{"title":"Silk® Flow Diverter Device for Intracranial Aneurysm Treatment: A Systematic Review and Meta-Analysis.","authors":"William A Florez,&nbsp;Ezequiel Garcia-Ballestas,&nbsp;Gabriel Alexander Quiñones-Ossa,&nbsp;Tariq Janjua,&nbsp;Subhas Konar,&nbsp;Amit Agrawal,&nbsp;Luis Rafael Moscote-Salazar","doi":"10.5469/neuroint.2021.00234","DOIUrl":"https://doi.org/10.5469/neuroint.2021.00234","url":null,"abstract":"<p><p>Flow diverters have become a critical instrument for complex aneurysms treatment. However, limited data are currently available regarding short and long-term outcomes for the Silk flow diverter. The objective of the study is to determine neurological prognosis and mortality rates for the Silk flow diversion device used in intracranial aneurysms. A systematic review with meta-analysis was performed using databases. The following descriptors were used for the search: \"SILK\", \"Flow Diverter\", \"Mortality\", and \"Prognosis\". The following data were extracted: mortality, good functional outcome, Glasgow outcome scale, complete or near-complete occlusion rates, rate of retreatment, and complications (thromboembolic and hemorrhagic complications). A total of 14 studies were selected. Among the 14 studies, 13 were retrospective observational cohort studies and 1 was a prospective observational cohort study. The mortality rate was 2.84%. The clinical good outcomes rate was 93.3%. The poor outcome rate was 6.6%. The overall thromboembolic complication rate was 6.06% (95% confidence interval [CI] 0.00-6.37, P=0.12, I2=3.13%). The total hemorrhagic complication rate was 1.62% (95% CI 0.00-5.34, P=0.28, I2=1.56%). The complete aneurysm occlusion rate was 80.4% (95% CI 8.65-9.38, P<0.0001, I2=9.09%). The Silk diverter device has a good safety and efficacy profile for treating intracranial aneurysms with high complete occlusion rates.</p>","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":"16 3","pages":"222-231"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ab/fc/neuroint-2021-00234.PMC8561040.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39431767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Embolization Tactics of Spinal Epidural Arteriovenous Fistulas. 脊髓硬膜外动静脉瘘的栓塞策略。
Q4 CLINICAL NEUROLOGY Pub Date : 2021-11-01 Epub Date: 2021-08-24 DOI: 10.5469/neuroint.2021.00220
Abdulrahman Hamad Al-Abdulwahhab, Yunsun Song, Boseong Kwon, Dae Chul Suh

Purpose: Spinal epidural arteriovenous fistulas (SEDAVFs) show an epidural venous sac often with venous congestive myelopathy (VCM) due to intradural reflux at a remote level to which a transarterial approach would be difficult. We present 12 cases of SEDAVF with VCM and describe 3 main tactics for effective transarterial embolization.

Materials and methods: Among 152 patients with spinal vascular malformations diagnosed in our tertiary hospital between 1993 and 2019, 12 SEDAVF patients with VCM were included. Three different transarterial embolization tactics were applied according to the vascular configuration and microcatheter accessibility. We evaluated treatment results and clinical outcomes before and after treatment.

Results: Transarterial embolization with glue (20-30%) was performed in all patients. The embolization tactics applied in 12 patients were preferential flow (n=2), plug-and-push (n=6), and filling of the venous sac (n=4). Total occlusion of the SEDAVF, including intradural reflux, was achieved in 11 (91.7%) of 12 patients, and partial occlusion was achieved in 1 patient. No periprocedural complications were reported. Spinal cord edema was improved in all patients for an average of 18 months after treatment. Clinical functional outcome in terms of the pain, sensory, motor, and sphincter scale and modified Rankin scores improved during a mean 25-month follow-up (6.3 vs. 3.3, P=0.002; 3.6 vs. 2.3, P=0.002, respectively).

Conclusion: Endovascular treatment for 12 SEDAVF patients with VCM achieved a total occlusion rate of 91.7% without any periprocedural complication. The combined embolization tactics can block intradural reflux causing VCM, resulting in overall good clinical outcomes.

目的:脊髓硬膜外动静脉瘘(sedavf)表现为硬膜外静脉囊,常伴有静脉充血性脊髓病(VCM),由于硬膜内反流在远端水平,经动脉入路是困难的。我们报告了12例SEDAVF合并VCM的病例,并描述了三种有效的经动脉栓塞策略。材料与方法:纳入我院1993 - 2019年诊断的152例脊柱血管畸形患者,其中12例为SEDAVF合并VCM患者。根据血管形态和微导管可及性,采用三种不同的经动脉栓塞策略。我们评估治疗前后的治疗效果和临床结果。结果:所有患者均行经动脉胶栓塞术(20 ~ 30%)。12例患者采用的栓塞策略为优先流(n=2)、推塞(n=6)、静脉囊填充(n=4)。12例患者中有11例(91.7%)实现了SEDAVF的完全闭塞,包括硬膜内反流,1例患者实现了部分闭塞。无围手术期并发症报告。所有患者的脊髓水肿在治疗后平均18个月得到改善。在平均25个月的随访期间,疼痛、感觉、运动和括约肌评分和改良Rankin评分的临床功能结局均有所改善(6.3 vs 3.3, P=0.002;3.6 vs. 2.3, P=0.002)。结论:血管内治疗12例SEDAVF合并VCM患者,总闭塞率达91.7%,无围手术期并发症。联合栓塞策略可阻断引起VCM的硬膜内反流,总体临床效果良好。
{"title":"Embolization Tactics of Spinal Epidural Arteriovenous Fistulas.","authors":"Abdulrahman Hamad Al-Abdulwahhab,&nbsp;Yunsun Song,&nbsp;Boseong Kwon,&nbsp;Dae Chul Suh","doi":"10.5469/neuroint.2021.00220","DOIUrl":"https://doi.org/10.5469/neuroint.2021.00220","url":null,"abstract":"<p><strong>Purpose: </strong>Spinal epidural arteriovenous fistulas (SEDAVFs) show an epidural venous sac often with venous congestive myelopathy (VCM) due to intradural reflux at a remote level to which a transarterial approach would be difficult. We present 12 cases of SEDAVF with VCM and describe 3 main tactics for effective transarterial embolization.</p><p><strong>Materials and methods: </strong>Among 152 patients with spinal vascular malformations diagnosed in our tertiary hospital between 1993 and 2019, 12 SEDAVF patients with VCM were included. Three different transarterial embolization tactics were applied according to the vascular configuration and microcatheter accessibility. We evaluated treatment results and clinical outcomes before and after treatment.</p><p><strong>Results: </strong>Transarterial embolization with glue (20-30%) was performed in all patients. The embolization tactics applied in 12 patients were preferential flow (n=2), plug-and-push (n=6), and filling of the venous sac (n=4). Total occlusion of the SEDAVF, including intradural reflux, was achieved in 11 (91.7%) of 12 patients, and partial occlusion was achieved in 1 patient. No periprocedural complications were reported. Spinal cord edema was improved in all patients for an average of 18 months after treatment. Clinical functional outcome in terms of the pain, sensory, motor, and sphincter scale and modified Rankin scores improved during a mean 25-month follow-up (6.3 vs. 3.3, P=0.002; 3.6 vs. 2.3, P=0.002, respectively).</p><p><strong>Conclusion: </strong>Endovascular treatment for 12 SEDAVF patients with VCM achieved a total occlusion rate of 91.7% without any periprocedural complication. The combined embolization tactics can block intradural reflux causing VCM, resulting in overall good clinical outcomes.</p>","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":"16 3","pages":"252-259"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/b0/neuroint-2021-00220.PMC8561027.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39337367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Ethic Statement Correction: Peri-Aneurysmal Brain Edema in Native and Treated Aneurysms: The Role of Thrombosis. 伦理声明更正:原生和治疗动脉瘤的动脉瘤周围脑水肿:血栓形成的作用。
Q4 CLINICAL NEUROLOGY Pub Date : 2021-11-01 Epub Date: 2021-04-05 DOI: 10.5469/neuroint.2020.00255.e1
Valeria Onofrj, Donatella Tampieri, Alessandro Cianfoni, Elisa Ventura
{"title":"Ethic Statement Correction: Peri-Aneurysmal Brain Edema in Native and Treated Aneurysms: The Role of Thrombosis.","authors":"Valeria Onofrj,&nbsp;Donatella Tampieri,&nbsp;Alessandro Cianfoni,&nbsp;Elisa Ventura","doi":"10.5469/neuroint.2020.00255.e1","DOIUrl":"https://doi.org/10.5469/neuroint.2020.00255.e1","url":null,"abstract":"","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":"16 3","pages":"303"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/d2/neuroint-2020-00255-e1.PMC8561034.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38831602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unruptured Intracranial Aneurysm: Screening, Prevalence and Risk Factors. 未破裂颅内动脉瘤:筛查,患病率和危险因素。
Q4 CLINICAL NEUROLOGY Pub Date : 2021-11-01 Epub Date: 2021-10-25 DOI: 10.5469/neuroint.2021.00451
Bum-Soo Kim
Subarachnoid hemorrhage (SAH) due to ruptured intracranial aneurysm is life-threatening, and screening for unruptured intracranial aneurysm (UIA) in selected patients and providing treatment before rupture of selected aneurysms are medically and economically beneficial. Therefore, screening for UIA must be tailored to specific populations in order to balance the prevalence and risk of UIA, cost-effectiveness of screening tests, and the availability of effective and safe treatment. Of these, estimating the prevalence and risk factor of UIA by epidemiological study is methodologically challenging, requiring an optimal cohort for prospective studies with a large amount of data. In the last issue, Kim and colleagues evaluated the prevalence (3.77%) and risk factors (female predominance and hypertension) of UIAs from healthy individuals who underwent brain magnetic resonance angiography using 3T magnetic resonance imaging as part of a routine health examination. There have been several other studies evaluating the prevalence and risk factors of UIA in the literature. The studies were variable with regards to the population studied, indication for imaging, and method of detection (Table 1). The reported prevalence of UIA in the literature ranged 1.8–8.8%, and was 3.2% according to combined results from a systematic review and meta-analyses, which was also similar to the result (3.77%) from Kim et al. In evaluating the risk factors of UIA, it was more common in women, older age, smokers, patients with hypertension, autosomal dominant polycystic kidney disease (ADPKD), or in individuals with family history of intracranial aneurysm of SAH. Consequently, Korean Clinical Practice Guidelines for UIA currently recommended that UIA should be screened according to the following three categories; 1) patients who have 2 or more first-degree relatives with an intracranial aneurysm; 2) patients with ADPKD; and 3) regular screening tests for new aneurysms for patients previously treated with aneurysmal SAH. Although the current guidelines do not support widespread screening for intracranial aneurysms in the general population, additional screening may be considered in patients with other genetic or medical conditions associated with intracranial aneurysms. Recently, according to the data from Korean National Health Insurance Service (NHIS), the number of treatments for UIA has increased because of the increased detection rate as well as increase in number of hospitals capable Correspondence to: Bum-soo Kim, MD Department of Radiology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea Tel: +82-2-2258-9639 Fax: +82-2-599-6771 E-mail: bkim.neurorad@gmail.com
{"title":"Unruptured Intracranial Aneurysm: Screening, Prevalence and Risk Factors.","authors":"Bum-Soo Kim","doi":"10.5469/neuroint.2021.00451","DOIUrl":"https://doi.org/10.5469/neuroint.2021.00451","url":null,"abstract":"Subarachnoid hemorrhage (SAH) due to ruptured intracranial aneurysm is life-threatening, and screening for unruptured intracranial aneurysm (UIA) in selected patients and providing treatment before rupture of selected aneurysms are medically and economically beneficial. Therefore, screening for UIA must be tailored to specific populations in order to balance the prevalence and risk of UIA, cost-effectiveness of screening tests, and the availability of effective and safe treatment. Of these, estimating the prevalence and risk factor of UIA by epidemiological study is methodologically challenging, requiring an optimal cohort for prospective studies with a large amount of data. In the last issue, Kim and colleagues evaluated the prevalence (3.77%) and risk factors (female predominance and hypertension) of UIAs from healthy individuals who underwent brain magnetic resonance angiography using 3T magnetic resonance imaging as part of a routine health examination. There have been several other studies evaluating the prevalence and risk factors of UIA in the literature. The studies were variable with regards to the population studied, indication for imaging, and method of detection (Table 1). The reported prevalence of UIA in the literature ranged 1.8–8.8%, and was 3.2% according to combined results from a systematic review and meta-analyses, which was also similar to the result (3.77%) from Kim et al. In evaluating the risk factors of UIA, it was more common in women, older age, smokers, patients with hypertension, autosomal dominant polycystic kidney disease (ADPKD), or in individuals with family history of intracranial aneurysm of SAH. Consequently, Korean Clinical Practice Guidelines for UIA currently recommended that UIA should be screened according to the following three categories; 1) patients who have 2 or more first-degree relatives with an intracranial aneurysm; 2) patients with ADPKD; and 3) regular screening tests for new aneurysms for patients previously treated with aneurysmal SAH. Although the current guidelines do not support widespread screening for intracranial aneurysms in the general population, additional screening may be considered in patients with other genetic or medical conditions associated with intracranial aneurysms. Recently, according to the data from Korean National Health Insurance Service (NHIS), the number of treatments for UIA has increased because of the increased detection rate as well as increase in number of hospitals capable Correspondence to: Bum-soo Kim, MD Department of Radiology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea Tel: +82-2-2258-9639 Fax: +82-2-599-6771 E-mail: bkim.neurorad@gmail.com","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":"16 3","pages":"201-203"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8b/9d/neuroint-2021-00451.PMC8561037.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39551049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Monitoring Radiation Doses during Diagnostic and Therapeutic Neurointerventional Procedures: Multicenter Study for Establishment of Reference Levels. 在诊断和治疗性神经介入过程中监测辐射剂量:建立参考水平的多中心研究。
Q4 CLINICAL NEUROLOGY Pub Date : 2021-11-01 Epub Date: 2021-10-26 DOI: 10.5469/neuroint.2021.00437
Yon-Kwon Ihn, Bum-Soo Kim, Hae Woong Jeong, Sang Hyun Suh, Yoo Dong Won, Young-Jun Lee, Dong Joon Kim, Pyong Jeon, Chang-Woo Ryu, Sang-Il Suh, Dae Seob Choi, See Sung Choi, Sang Heum Kim, Jun Soo Byun, Jieun Rho, Yunsun Song, Woo Sang Jeong, Noah Hong, Sung Hyun Baik, Jeong Jin Park, Soo Mee Lim, Jung-Jae Kim, Woong Yoon
Purpose To assess patient radiation doses during diagnostic and therapeutic neurointerventional procedures from multiple centers and propose dose reference level (RL). Materials and Methods Consecutive neurointerventional procedures, performed in 22 hospitals from December 2020 to June 2021, were retrospectively studied. We collected data from a sample of 429 diagnostic and 731 therapeutic procedures. Parameters including dose-area product (DAP), cumulative air kerma (CAK), fluoroscopic time (FT), and total number of image frames (NI) were obtained. RL were calculated as the 3rd quartiles of the distribution. Results Analysis of 1160 procedures from 22 hospitals confirmed the large variability in patient dose for similar procedures. RLs in terms of DAP, CAK, FT, and NI were 101.6 Gy·cm2, 711.3 mGy, 13.3 minutes, and 637 frames for cerebral angiography, 199.9 Gy·cm2, 3,458.7 mGy, 57.3 minutes, and 1,000 frames for aneurysm coiling, 225.1 Gy·cm2, 1,590 mGy, 44.7 minutes, and 800 frames for stroke thrombolysis, 412.3 Gy·cm2, 4,447.8 mGy, 99.3 minutes, and 1,621.3 frames for arteriovenous malformation (AVM) embolization, respectively. For all procedures, the results were comparable to most of those already published. Statistical analysis showed male and presence of procedural complications were significant factors in aneurysmal coiling. Male, number of passages, and procedural combined technique were significant factors in stroke thrombolysis. In AVM embolization, a significantly higher radiation dose was found in the definitive endovascular cure group. Conclusion Various RLs introduced in this study promote the optimization of patient doses in diagnostic and therapeutic interventional neuroradiology procedures. Proposed 3rd quartile DAP (Gy·cm2) values were 101.6 for diagnostic cerebral angiography, 199.9 for aneurysm coiling, 225.1 for stroke thrombolysis, and 412.3 for AVM embolization. Continual evolution of practices and technologies requires regular updates of RLs.
目的:评估多中心神经介入诊疗过程中患者放射剂量,提出剂量参考水平(RL)。材料和方法:回顾性研究2020年12月至2021年6月22家医院连续进行的神经介入手术。我们收集了429例诊断和731例治疗程序的样本数据。获得剂量面积积(DAP)、累积空气孔径(CAK)、透视时间(FT)和总图像帧数(NI)等参数。RL按分布的第三个四分位数计算。结果:对来自22家医院的1160例手术的分析证实,类似手术的患者剂量存在很大差异。脑血管造影的DAP、CAK、FT和NI的RLs分别为101.6 Gy·cm2、711.3 Gy·cm2、13.3分钟和637帧,动脉瘤缠绕的RLs分别为199.9 Gy·cm2、3458.7 Gy、57.3分钟和1000帧,脑卒中溶栓的RLs分别为225.1 Gy·cm2、1590 Gy、44.7分钟和800帧,动静脉畸形(AVM)栓塞的RLs分别为412.3 Gy·cm2、447.8 Gy、99.3分钟和1621.3帧。对于所有程序,结果与大多数已发表的结果相当。统计分析显示,男性和手术并发症是动脉瘤卷取的重要因素。男性、通道数和手术联合技术是脑卒中溶栓的重要因素。在AVM栓塞中,明确的血管内治疗组的放射剂量明显更高。结论:本研究中引入的各种RLs促进了介入神经放射学诊断和治疗过程中患者剂量的优化。脑血管造影诊断的第三四分位数DAP (Gy·cm2)值为101.6,动脉瘤卷绕诊断为199.9,脑卒中溶栓诊断为225.1,AVM栓塞诊断为412.3。实践和技术的不断发展需要定期更新RLs。
{"title":"Monitoring Radiation Doses during Diagnostic and Therapeutic Neurointerventional Procedures: Multicenter Study for Establishment of Reference Levels.","authors":"Yon-Kwon Ihn,&nbsp;Bum-Soo Kim,&nbsp;Hae Woong Jeong,&nbsp;Sang Hyun Suh,&nbsp;Yoo Dong Won,&nbsp;Young-Jun Lee,&nbsp;Dong Joon Kim,&nbsp;Pyong Jeon,&nbsp;Chang-Woo Ryu,&nbsp;Sang-Il Suh,&nbsp;Dae Seob Choi,&nbsp;See Sung Choi,&nbsp;Sang Heum Kim,&nbsp;Jun Soo Byun,&nbsp;Jieun Rho,&nbsp;Yunsun Song,&nbsp;Woo Sang Jeong,&nbsp;Noah Hong,&nbsp;Sung Hyun Baik,&nbsp;Jeong Jin Park,&nbsp;Soo Mee Lim,&nbsp;Jung-Jae Kim,&nbsp;Woong Yoon","doi":"10.5469/neuroint.2021.00437","DOIUrl":"https://doi.org/10.5469/neuroint.2021.00437","url":null,"abstract":"Purpose To assess patient radiation doses during diagnostic and therapeutic neurointerventional procedures from multiple centers and propose dose reference level (RL). Materials and Methods Consecutive neurointerventional procedures, performed in 22 hospitals from December 2020 to June 2021, were retrospectively studied. We collected data from a sample of 429 diagnostic and 731 therapeutic procedures. Parameters including dose-area product (DAP), cumulative air kerma (CAK), fluoroscopic time (FT), and total number of image frames (NI) were obtained. RL were calculated as the 3rd quartiles of the distribution. Results Analysis of 1160 procedures from 22 hospitals confirmed the large variability in patient dose for similar procedures. RLs in terms of DAP, CAK, FT, and NI were 101.6 Gy·cm2, 711.3 mGy, 13.3 minutes, and 637 frames for cerebral angiography, 199.9 Gy·cm2, 3,458.7 mGy, 57.3 minutes, and 1,000 frames for aneurysm coiling, 225.1 Gy·cm2, 1,590 mGy, 44.7 minutes, and 800 frames for stroke thrombolysis, 412.3 Gy·cm2, 4,447.8 mGy, 99.3 minutes, and 1,621.3 frames for arteriovenous malformation (AVM) embolization, respectively. For all procedures, the results were comparable to most of those already published. Statistical analysis showed male and presence of procedural complications were significant factors in aneurysmal coiling. Male, number of passages, and procedural combined technique were significant factors in stroke thrombolysis. In AVM embolization, a significantly higher radiation dose was found in the definitive endovascular cure group. Conclusion Various RLs introduced in this study promote the optimization of patient doses in diagnostic and therapeutic interventional neuroradiology procedures. Proposed 3rd quartile DAP (Gy·cm2) values were 101.6 for diagnostic cerebral angiography, 199.9 for aneurysm coiling, 225.1 for stroke thrombolysis, and 412.3 for AVM embolization. Continual evolution of practices and technologies requires regular updates of RLs.","PeriodicalId":19140,"journal":{"name":"Neurointervention","volume":"16 3","pages":"240-251"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/28/2f/neuroint-2021-00437.PMC8561028.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39556453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Neurointervention
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1